2024 KSoLA consensus on secondary dyslipidemia

Korean J Intern Med. 2024 Sep;39(5):717-730. doi: 10.3904/kjim.2024.156. Epub 2024 Aug 30.

Abstract

Elevated blood cholesterol and triglyceride levels induced by secondary causes are frequently observed. The identification and appropriate handling of these causes are essential for secondary dyslipidemia treatment. Major secondary causes of hypercholesterolemia and hypertriglyceridemia include an unhealthy diet, diseases and metabolic conditions affecting lipid levels, and therapeutic side effects. It is imperative to correct secondary causes prior to initiating conventional lipid-lowering therapy. Guideline-based lipid therapy can then be administered based on the subsequent lipid levels.

Keywords: Diagnosis; Drug-related side effects and adverse reactions; Food; Lipoproteins; Metabolism.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Biomarkers / blood
  • Consensus*
  • Dyslipidemias* / blood
  • Dyslipidemias* / diagnosis
  • Dyslipidemias* / drug therapy
  • Dyslipidemias* / therapy
  • Humans
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / diagnosis
  • Hypercholesterolemia / drug therapy
  • Hypertriglyceridemia / blood
  • Hypertriglyceridemia / diagnosis
  • Hypertriglyceridemia / therapy
  • Hypolipidemic Agents* / therapeutic use
  • Risk Factors
  • Treatment Outcome
  • Triglycerides / blood

Substances

  • Hypolipidemic Agents
  • Biomarkers
  • Triglycerides